Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Alison Tobias

Physician Assistant, Medical Beachwood, OH Physician Assistant

NPI 1881110799 CMS profile 10568888

3755 Orange Pl Ste 101, Beachwood, OH 44122

Open in the dashboard

General payments

$6,972

417 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alison Tobias of Beachwood, OH is reported in the CMS Open Payments database as having received $6,972 across 417 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,376 57
2024 General $1,370 75
2023 General $1,447 81
2022 General $1,485 103
2021 General $1,295 101

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alison Tobias
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Alison Tobias were reported at $1,376. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Alison Tobias Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $1,295 $156 $41–$563 $132
2022 $1,485 $185 $55–$649 $149
2023 $1,447 $199 $58–$717 $160
2024 $1,370 $206 $62–$740 $164
2025 $1,376 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $1,306 72 payments
  2. Janssen Pharmaceuticals, Inc $1,063 124 payments
  3. Merck Sharp & Dohme Corporation $775 35 payments
  4. Novo Nordisk Inc $624 36 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $618 28 payments
  6. Alnylam Pharmaceuticals Inc. $475 23 payments
  7. Scpharmaceuticals Inc. $458 20 payments
  8. Boston Scientific Corporation $304 12 payments
  9. Amgen Inc. $300 15 payments
  10. AstraZeneca Pharmaceuticals LP $232 14 payments
  11. Other $816 38 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,972 417 payments
Products named General payments · program years 2021–2025
  1. XARELTO $1,063 124 payments
  2. VERQUVO $935 42 payments
  3. ENTRESTO $623 34 payments
  4. LEQVIO Cardiology/Vascular Diseases $620 34 payments
  5. Ozempic $567 33 payments
  6. RYBELSUS $567 33 payments
  7. ONPATTRO $475 23 payments
  8. FUROSCIX $458 20 payments
  9. JARDIANCE $367 18 payments
  10. LEQVIO Cardiovascular $313 17 payments
  11. Other $2,207 104 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

417 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record